Omk1® eye drops

Omk1^® is a sterile ophthalmic solution containing Citicoline 2% and high molecular weight hyaluronic acid 0,2%.

The product has been developed by Omikron Italia and it is covered by International Patent for glaucoma treatment (EU, USA and Japan).

Omk1^® is registered in Italy and also in other 39 EU and extra-EU Countries as Medical Device with CE Marking with the following intended use: “Thanks to the presence of Citicoline and to its structural action on retinal ganglion cells, it is indicated as coadjuvant to antihypertensive therapy in Glaucomatous patients.”